In the latest trading session, DaVita Healthcare (DVA) closed at $161.57, adjusting -0.01% from the previous day’s closing price. This stock price change lagged the S&P 500’s daily gain of 0.25%. Meanwhile, the Dow rose 0.2% and the tech-heavy Nasdaq added 0.56%.Heading into today, shares of the kidney dialysis provider had gained 4.41% over the past month, outpacing the Medical sector’s loss of 1.51% and the S&P 500’s gain of 1.65% in that time period.DaVita HealthCare’s upcoming earnings release will be of great interest to investors, as the company is expected to post EPS of $2.76, which would represent a…
Author: admin
In a bold move that could reshape the healthcare technology landscape, Microsoft MSFT recently announced a series of artificial intelligence innovations aimed at transforming patient care and clinical workflows. The technology giant's latest offering, announced as part of the Microsoft Cloud for Healthcare platform, marks a major push into the lucrative but complex healthcare market.For investors, Microsoft's healthcare AI efforts present both an opportunity and a challenge. On the other hand, the global digital health market is expected to grow significantly in the coming years, offering significant revenue potential. On the other hand, developing and deploying these technologies requires significant…
In the latest trading session, DaVita HealthCare (DVA) closed at $159.07, adjusting -0.03% from previous closing price. The stock outperformed the S&P 500, which fell 0.17% on the day. Meanwhile, the Dow Jones Industrial Average fell 0.44%, and the tech-heavy Nasdaq fell 0.04%.Shares of the kidney dialysis provider have gained 5.11% over the past month, leading the Medical sector's decline of 3.8% and the S&P 500's gain of 1.25%.Analysts and investors alike will be keeping an eye on DaVita Healthcare's performance in its upcoming earnings release. The company's future EPS is expected to be $2.76, which would represent a -3.16%…
Avianna Healthcare (AVAH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.03 per share a year ago. These figures have been adjusted for non-recurring items. This quarterly report represents a 300% earnings surprise. A quarter ago, it was expected that this home health care services provider would post a loss of $0.02 per share when it actually produced earnings of $0.01, delivering a surprise 150% return. The company has surpassed consensus EPS estimates four times over the last four quarters. Avianna,…
If you want to find strong stocks in the medical industry, it would be wise to look for companies within the group that are outperforming their peers. Could Avianna Healthcare (AVAH) be one of those stocks this year? We might be able to answer that question by looking at the company's year-to-date performance compared to its medical peers.Avianna Healthcare is one of 1,025 individual stocks in the Healthcare sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed from highest to lowest in terms of the average…
Chicago, IL – November 5, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in this blog include Healthcare Select Sector SPDR ETF XLV, Tenet Healthcare THC, Invesco Dynamic Building & Construction ETF PKB, and Dicom Industries DY. Highlights from Monday's analyst blog include: The U.S. economy added 12,000 jobs in October, CNBC cited, a sharp drop from September and less than the 100,000 jobs expected by the Dow Jones. The Boeing strike is estimated…
company logoGlobal digital payments in the healthcare marketGlobal digital payments in the healthcare marketDUBLIN, Oct. 10, 2024 (GLOBE NEWSWIRE) — “Digital Payments in Healthcare Market – Global Industry Size, Share, Trends, Opportunities, Forecast, 2019 to 2029” report is a service of ResearchAndMarkets.com added to.The global digital payments in healthcare market was valued at USD 10.4 billion in 2023 and is expected to reach USD 21.62 billion by 2029, growing at a CAGR of 12.80%. This market is experiencing significant growth due to the ongoing digital transformation in the healthcare sector. Digital payment solutions have become essential as healthcare providers and…
Healthcare analytics market Healthcare analytics market DUBLIN, Oct. 31, 2024 (GLOBE NEWSWIRE) — By Type (Predictive, Diagnostics), By Application (Claims, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health) The “Healthcare Analytics Market” “End Users (Payers, Hospitals, ACOs, ASCs, Governments, Clinics), Regions: Global Forecast to 2029” report has been added to ResearchAndMarkets.com's offering.The global healthcare analytics market is projected to reach USD 133.19 billion by 2029 from USD 44.83 billion in 2024, at a CAGR of 24.3% from 2024 to 2029. The proliferation of electronic health records (EHR) is accelerating the growth of the healthcare analytics market. In…
Health care isn't the first sector that income investors look to for high dividend yields. Healthcare ranks 8th out of 11 S&P 500 sectors ranked based on average dividend yield.However, many healthcare stocks offer impressive dividends. Some are good choices, some are not. Here's one super-high-yield healthcare stock to buy empty-handed and avoid.buy pfizerSome investors may consider Pfizer (New York Stock Exchange: PFE) Healthcare stocks should be avoided, rather than bought empty-handed. One need only look at the drug company's recent history to understand that perspective. Pfizer's stock price has fallen more than 50% from its all-time high in late…
If you own Walgreens Boots Alliance stock (Nasdaq: WBA) In the hope of a quick turnaround, I believe now is the time to cut losses on struggling pharmacy chains and allocate capital elsewhere. Here’s why.The common investment theory for this stock has now disappeared.One criterion that helps investors decide when to sell a stock is whether the investment thesis they based their purchase on still holds true.Let’s say you bought Walgreens stock 10 years ago, expecting it to be a safe stock that would generate steady dividend income and moderate stock price appreciation. You might also have expected that its…